期刊文献+

RBP4与炎性因子水平对2型糖尿病下肢动脉病变的诊断价值 被引量:3

The Diagnostic Value of RBP4 Levels and Inflammatory Factors in Type 2 Diabetic with Lower Extremity Arterial Disease
下载PDF
导出
摘要 目的 探讨RBP4与炎性因子水平对2型糖尿病下肢动脉病变的临床意义及诊断价值.方法 选择糖尿病患者118例,根据踝肱指数(ABI)分为单纯2型糖尿病组(A组,ABI 1.30 ~ 0.91),中度闭塞组(B组,ABI 0.41~0.90)、重度闭塞组(C组,ABI <0.40),分别有49例、38例、31例.分别检测各组RBP、ABI及IL-6、IL-8、TNF-仅.结果 B组RBP、ABI均较A组差异有统计学意义(P<0.05),C组RBP及ABI较A组及B组差异有统计学意义(P<0.05).B组IL-6、IL-8较A组差异有统计学意义(P<0.05),C组IL-6、IL-8、TNF-α较A、B组有升高(P<0.05).RBP与IL-6、IL-8、TNF-仅有相关性(P<0.05),ABI与IL-6、IL-8有相关性(P<0.05).结论 RBP4是判断2型糖尿病下肢动脉病变进展的重要指标,与炎性因子同时参与2型糖尿病下肢动脉病变的发展过程. Objective To investigate the diagnostic value of RBP4 levels and inflammatory factors in type 2 diabetic with lower extremity arterial disease.Methods 118 cases were divided into simple type 2 diabetes group (A,ABI 1.30 ~ 0.91),severe occlusion group (group B,ABI 0.41 ~ 0.90),severe occlusion group (group C,ABI<0.40) according to the ankle-brachial index (ABI),there were 49 cases,38 cases,31 cases in the three groups,respectively.RBP,ABI,and IL-6,IL-8,TNF-α were detected in each group.Results There was significant difference in RBP and ABI between group A and group B (P<0.05),and between group C and group A and B (P<0.05).There was significant difference in IL-6 and IL-8 between group A and group B (P<0.05),and in the levels of IL-6,IL-8,TNF-α in group C were significantly higher than those in group A and B (P<0.05).RBP and IL-6,IL-8,TNF-α were significantly positively correlated (P<0.05),ABI and IL-6,IL-8 were significantly negatively correlated (P<0.05).Conclusions RBP4 can help to determine the type 2 diabetic patients with lower extremity arterial disease and work as an important indicator of progress,while inflammatory factors are involved in the development process of lower extremity arterial disease.
出处 《昆明医科大学学报》 CAS 2014年第8期99-102,共4页 Journal of Kunming Medical University
基金 陕西省科技攻关基金资助项目(2011K14-04-05)
关键词 RBP4 炎性因子 ABI 糖尿病 RBP4 Inflammatory factors ABI Diabetes
  • 相关文献

参考文献12

  • 1PRAKASH J. Non-diabetic renal disease (NDRD) in pa- tients with type 2 diabetes meUitus (type 2 DM)[J]. J As- soc Physicians India, 2013,61 (3): 194- 199.
  • 2MIRANDO A J, LIU Z, MOORE T, et al. RBP-Jkappa-de- pendent Notch signaling is required for murine articular cartilage and joint maintenance [J]. Arthritis Rheum, 2013,65( 10):2 623-2 633.
  • 3CHEN Y R, FENG F, WANG L, et al. Deletion of RBP-J in dendritic cells compromises TLR-mediated DCactivation accompanied by abnormal eytoskeleton reorganization [J]. Mol Biol Rep,2013,40(2):1 531-1 539.
  • 4CHEN J M, CHANG C W, CHANG T H, et al. Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan [J]. PLoS One,2014,9 (2):e8 8434.
  • 5郭晨佳,李芳,陆荣柱.地理环境因素对糖尿病患者健康的影响[J].国外医学(医学地理分册),2013,34(4):263-266. 被引量:17
  • 6GOMENI R, HEIDBREDER C, FUDALA P J, et al. A m- odel-based approach to characterize the population phar- macokinetics and the relationship between the pharmacoki- netic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone [ J]. J ClinPharmaco1,2013,53( 10):1 010-1 019.
  • 7ZHOU S, FANG X, XIN H, et al. Correction:osteoprotege- fin inhibits calcification of vascular smooth muscle cell via down regulation of the notchl-RBP-Jkappa/Msx2 Signaling Pathway[ J ]. PLoS One, 2013,8(8) :546-559.
  • 8KAWAGUCHI R,ZHONG M,KASSAI M,et al. Differen- tial and isomer-specific modulation of vitamin a transport and the catalytic activities of the RBP receptor by retinoids [J]. J Membr Biol,2013,246(8):647-660.
  • 9LARABEE J L, SHAKIR S M, BARUA S, et al. Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBP-J and transducin-like enhancer of Split (TLE) [J]. J Biol Chem,2013,288 (30):21 526-21 536.
  • 10ZHOU S, FANG X, XIN H, et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regu- lation of the Notchl-RBP-Jkappa/Msx2 signaling pathway [J]. PLoS One,2013,8(7):e68 987.

二级参考文献31

  • 1王玉珍,许樟荣.第五届国际血管外科暨第一届国际糖尿病血管疾病会议(糖尿病足部分)纪要[J].中华糖尿病杂志(1006-6187),2005,13(2):152-153. 被引量:184
  • 2DICKINSON PJ, CARRINGTON AL, FROST GS, et al. Neurovascular disease, antioxidants and glycation in diabetes [J]. Diabetes Metab Res Rev, 2002-18 : 260-272.
  • 3CAMERON NE, EATON SE, COTTER MA, et al. Vascular factors and metabolic interactions in the pathogenesis of d!abetic neuropathy[J]. Diabetologia, 2001,44(11) : 1973-1988.
  • 4MILLS JL. Open bypass and endoluminal therapy; complementary techniques for revascularization in diabetic patients with critical limbs ischemia. Diabetes Metab Rev, 2008,24 (Suppl) :S34-S39.
  • 5ANDREW JM, BOULION MD, FRCP, et al. Comprehensive Foot Examination and Risk Assessment[J]. Diabetes Care, 2008,31, 1679-1686.
  • 6FAGLIA E, DALLA PAOLA L, CLERICI G, et al. Peripheral angioplasty as the first choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003 [J]. Eur J Vasc Endovasc Surg, 2005, 29:620- 627.
  • 7Curtiss B,Cook MD,Kay E,et al.Geoenvironmental Diabetology[J].J Diabetes Sci Technol,2011,5(4):834-842.
  • 8Ershow AG.Environmental influences on development of type 2 diabetes and obesity:challenges in personalizing prevention and management[J].J Diabetes Sci Technol,2009,3(4):727-034.
  • 9Mbanya JC.Global solidarity in a time of crisis:How IDF responded to the disaster in Haiti[J].Diabetes Res Clin Pract,2010,87(3):423-425.
  • 10Wiwanitkit V.Post-earthquake problem in management of patients with diabetes mellitus:a comment[J].Diabetes Metab Syndrome,1997,36(3):193-196.

共引文献34

同被引文献34

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部